clinical trial · NCT04338204
Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden
Pfizer·—·recruiting·n = 120
Ulcerative Colitistofacitinib
brief summary
This is a prospective observational study using data from an existing, ongoing National Swedish registry (SWIBREG). This study is designed to assess the effectiveness and treatment adherence of tofacitinib on clinical disease activity parameters in patients with ulcerative colitis in Swedish clinical practice. The study will also assess treatment adherence of tofacitinib using the Swedish Prescribed Drug Register.
started
Sep 14, 2020
primary completion
Mar 30, 2026
completion
Mar 30, 2026
last updated
Mar 13, 2026
official title
Observational Study of Tofacitinib in Ulcerative Colitis in Sweden (ODEN)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol